2021
DOI: 10.1007/s00423-021-02274-x
|View full text |Cite
|
Sign up to set email alerts
|

Preoperative computed tomography-assessed sarcopenia as a predictor of complications and long-term prognosis in patients with colorectal cancer: a systematic review and meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
17
1

Year Published

2022
2022
2023
2023

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 27 publications
(18 citation statements)
references
References 48 publications
0
17
1
Order By: Relevance
“…Of the studies combining different malignancies [30,32,49], two did not refer to SMI as a measure of sarcopenia alone, but Berardi et al used the combination of reduced muscle mass and strength as a definition of LSMM, while Valero et al applied TPA and TPV. Our overall results exhibit a somewhat lower OR for post-operative complications for liver resection than those published for gastrectomy or surgery for CRC [13,14].…”
Section: Discussioncontrasting
confidence: 45%
See 2 more Smart Citations
“…Of the studies combining different malignancies [30,32,49], two did not refer to SMI as a measure of sarcopenia alone, but Berardi et al used the combination of reduced muscle mass and strength as a definition of LSMM, while Valero et al applied TPA and TPV. Our overall results exhibit a somewhat lower OR for post-operative complications for liver resection than those published for gastrectomy or surgery for CRC [13,14].…”
Section: Discussioncontrasting
confidence: 45%
“…With regard to complications after surgery, an association between LSMM and post-operative outcomes according to the Clavien Dindo score was reported for cancer patients after gastrectomy (OR 2.17, 95% CI 1.53-3.08) [13] and surgery for colorectal cancer (OR = 1.82, 95% CI = 1.36-2.44) [14]. Single studies have found LSMM to be associated with post-operative complications for pancreatic cancer [42], yet a meta-analysis did not find a significant association (OR 0.96, 95% CI 0.78-1.19) [17].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Notably, skeletal muscle loss has been identified as an important factor affecting the prognosis of patients with cancer. 22 , 23 HGS is a simple and noninvasive indicator that reflects the muscle function of patients. Low HGS was reported to be associated with poor prognosis, providing additional information for the prognostic evaluation of patients with cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Sarcopenia has been identified as a poor prognostic marker in numerous cancers, including gastrointestinal tumors, lung cancer, head and neck cancer, and ovarian cancer [31][32][33][34][35][36][37][38][39][40][41]. It has been associated with increased post-operative complications, improved toxicity of systemic therapies, and decreased overall survival [17,[42][43][44]. Several meta-analyses among gynecological cancer patients showed an influence of sarcopenia on OS and progression-free survival (PFS).…”
Section: Discussionmentioning
confidence: 99%